APO Research
Talk to an analyst

APO RESEARCH · REPORT

Icodec Insulin

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Icodec Insulin Market Analysis and Forecast 2026-2032

29 December 2025198 pages

Choose your research edition.

Industry ResearchIcodec Insulin Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Icodec Insulin Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Icodec Insulin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Icodec Insulin Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Icodec Insulin Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Icodec Insulin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Icodec Insulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Icodec Insulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Icodec Insulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Icodec Insulin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Icodec Insulin include Paijin Biotechnology, Sanofi, Lilly, Gan&Lee Pharmaceuticals and Novo Nordisk, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Icodec Insulin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Icodec Insulin, also provides the sales of main regions and countries. Of the upcoming market potential for Icodec Insulin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Icodec Insulin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Icodec Insulin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Icodec Insulin sales, projected growth trends, production technology, application and end-user industry.

Icodec Insulin Segment by Company

Paijin Biotechnology

Sanofi

Lilly

Gan&Lee Pharmaceuticals

Novo Nordisk

Icodec Insulin Segment by Type

Long-acting

Medium-acting

Icodec Insulin Segment by Application

Hospital

Clinic

Icodec Insulin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icodec Insulin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Icodec Insulin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icodec Insulin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Icodec Insulin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Icodec Insulin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Icodec Insulin sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Icodec Insulin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Long-acting Major Manufacturers Table 3. Medium-acting Major Manufacturers Table 4. Global Icodec Insulin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Icodec Insulin Industry Trends Table 8. Icodec Insulin Industry Drivers Table 9. Icodec Insulin Industry Opportunities and Challenges Table 10. Icodec Insulin Industry Restraints Table 11. Global Icodec Insulin Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Icodec Insulin Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Icodec Insulin Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Icodec Insulin Revenue Market Share by Region (2021-2026) Table 15. Global Icodec Insulin Revenue Market Share by Region (2027-2032) Table 16. Global Icodec Insulin Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 17. Global Icodec Insulin Sales by Region (2021-2026) & (K Units) Table 18. Global Icodec Insulin Sales by Region (2027-2032) & (K Units) Table 19. Global Icodec Insulin Sales Market Share by Region (2021-2026) Table 20. Global Icodec Insulin Sales Market Share by Region (2027-2032) Table 21. Global Icodec Insulin Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Icodec Insulin Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Icodec Insulin Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Icodec Insulin Sales Market Share by Manufacturers (2021-2026) Table 25. Global Icodec Insulin Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Icodec Insulin Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Icodec Insulin Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Icodec Insulin Manufacturers, Product Type & Application Table 29. Global Icodec Insulin Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Icodec Insulin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Icodec Insulin Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Icodec Insulin Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Icodec Insulin Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Icodec Insulin Revenue Market Share by Type (2021-2026) Table 36. Global Icodec Insulin Revenue Market Share by Type (2027-2032) Table 37. Global Icodec Insulin Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 38. Global Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 39. Global Icodec Insulin Sales by Type (2027-2032) & (K Units) Table 40. Global Icodec Insulin Sales Market Share by Type (2021-2026) Table 41. Global Icodec Insulin Sales Market Share by Type (2027-2032) Table 42. Global Icodec Insulin Price by Type (2021-2026) & (US$/Unit) Table 43. Global Icodec Insulin Price by Type (2027-2032) & (US$/Unit) Table 44. Global Icodec Insulin Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Icodec Insulin Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Icodec Insulin Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Icodec Insulin Revenue Market Share by Application (2021-2026) Table 48. Global Icodec Insulin Revenue Market Share by Application (2027-2032) Table 49. Global Icodec Insulin Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 50. Global Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 51. Global Icodec Insulin Sales by Application (2027-2032) & (K Units) Table 52. Global Icodec Insulin Sales Market Share by Application (2021-2026) Table 53. Global Icodec Insulin Sales Market Share by Application (2027-2032) Table 54. Global Icodec Insulin Price by Application (2021-2026) & (US$/Unit) Table 55. Global Icodec Insulin Price by Application (2027-2032) & (US$/Unit) Table 56. Paijin Biotechnology Company Information Table 57. Paijin Biotechnology Business Overview Table 58. Paijin Biotechnology Icodec Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Paijin Biotechnology Icodec Insulin Product Portfolio Table 60. Paijin Biotechnology Recent Development Table 61. Sanofi Company Information Table 62. Sanofi Business Overview Table 63. Sanofi Icodec Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. Sanofi Icodec Insulin Product Portfolio Table 65. Sanofi Recent Development Table 66. Lilly Company Information Table 67. Lilly Business Overview Table 68. Lilly Icodec Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Lilly Icodec Insulin Product Portfolio Table 70. Lilly Recent Development Table 71. Gan&Lee Pharmaceuticals Company Information Table 72. Gan&Lee Pharmaceuticals Business Overview Table 73. Gan&Lee Pharmaceuticals Icodec Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Gan&Lee Pharmaceuticals Icodec Insulin Product Portfolio Table 75. Gan&Lee Pharmaceuticals Recent Development Table 76. Novo Nordisk Company Information Table 77. Novo Nordisk Business Overview Table 78. Novo Nordisk Icodec Insulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Novo Nordisk Icodec Insulin Product Portfolio Table 80. Novo Nordisk Recent Development Table 81. North America Icodec Insulin Revenue by Type (2021-2026) & (US$ Million) Table 82. North America Icodec Insulin Revenue by Type (2027-2032) & (US$ Million) Table 83. North America Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 84. North America Icodec Insulin Sales by Type (2027-2032) & (K Units) Table 85. North America Icodec Insulin Sales Price by Type (2021-2026) & (US$/Unit) Table 86. North America Icodec Insulin Sales Price by Type (2027-2032) & (US$/Unit) Table 87. North America Icodec Insulin Revenue by Application (2021-2026) & (US$ Million) Table 88. North America Icodec Insulin Revenue by Application (2027-2032) & (US$ Million) Table 89. North America Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 90. North America Icodec Insulin Sales by Application (2027-2032) & (K Units) Table 91. North America Icodec Insulin Sales Price by Application (2021-2026) & (US$/Unit) Table 92. North America Icodec Insulin Sales Price by Application (2027-2032) & (US$/Unit) Table 93. North America Icodec Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Icodec Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 95. North America Icodec Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 96. North America Icodec Insulin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 97. North America Icodec Insulin Sales by Country (2021-2026) & (K Units) Table 98. North America Icodec Insulin Sales by Country (2027-2032) & (K Units) Table 99. North America Icodec Insulin Sales Price by Country (2021-2026) & (US$/Unit) Table 100. North America Icodec Insulin Sales Price by Country (2027-2032) & (US$/Unit) Table 101. United States Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 102. Canada Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 103. Mexico Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 104. Europe Icodec Insulin Revenue by Type (2021-2026) & (US$ Million) Table 105. Europe Icodec Insulin Revenue by Type (2027-2032) & (US$ Million) Table 106. Europe Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 107. Europe Icodec Insulin Sales by Type (2027-2032) & (K Units) Table 108. Europe Icodec Insulin Sales Price by Type (2021-2026) & (US$/Unit) Table 109. Europe Icodec Insulin Sales Price by Type (2027-2032) & (US$/Unit) Table 110. Europe Icodec Insulin Revenue by Application (2021-2026) & (US$ Million) Table 111. Europe Icodec Insulin Revenue by Application (2027-2032) & (US$ Million) Table 112. Europe Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 113. Europe Icodec Insulin Sales by Application (2027-2032) & (K Units) Table 114. Europe Icodec Insulin Sales Price by Application (2021-2026) & (US$/Unit) Table 115. Europe Icodec Insulin Sales Price by Application (2027-2032) & (US$/Unit) Table 116. Europe Icodec Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Icodec Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 118. Europe Icodec Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 119. Europe Icodec Insulin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 120. Europe Icodec Insulin Sales by Country (2021-2026) & (K Units) Table 121. Europe Icodec Insulin Sales by Country (2027-2032) & (K Units) Table 122. Europe Icodec Insulin Sales Price by Country (2021-2026) & (US$/Unit) Table 123. Europe Icodec Insulin Sales Price by Country (2027-2032) & (US$/Unit) Table 124. Germany Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 125. France Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 126. U.K. Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 127. Italy Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 128. Russia Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 129. Spain Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 130. Netherlands Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 131. Switzerland Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 132. Sweden Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 133. Poland Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 134. China Icodec Insulin Revenue by Type (2021-2026) & (US$ Million) Table 135. China Icodec Insulin Revenue by Type (2027-2032) & (US$ Million) Table 136. China Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 137. China Icodec Insulin Sales by Type (2027-2032) & (K Units) Table 138. China Icodec Insulin Sales Price by Type (2021-2026) & (US$/Unit) Table 139. China Icodec Insulin Sales Price by Type (2027-2032) & (US$/Unit) Table 140. China Icodec Insulin Revenue by Application (2021-2026) & (US$ Million) Table 141. China Icodec Insulin Revenue by Application (2027-2032) & (US$ Million) Table 142. China Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 143. China Icodec Insulin Sales by Application (2027-2032) & (K Units) Table 144. China Icodec Insulin Sales Price by Application (2021-2026) & (US$/Unit) Table 145. China Icodec Insulin Sales Price by Application (2027-2032) & (US$/Unit) Table 146. Asia Icodec Insulin Revenue by Type (2021-2026) & (US$ Million) Table 147. Asia Icodec Insulin Revenue by Type (2027-2032) & (US$ Million) Table 148. Asia Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 149. Asia Icodec Insulin Sales by Type (2027-2032) & (K Units) Table 150. Asia Icodec Insulin Sales Price by Type (2021-2026) & (US$/Unit) Table 151. Asia Icodec Insulin Sales Price by Type (2027-2032) & (US$/Unit) Table 152. Asia Icodec Insulin Revenue by Application (2021-2026) & (US$ Million) Table 153. Asia Icodec Insulin Revenue by Application (2027-2032) & (US$ Million) Table 154. Asia Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 155. Asia Icodec Insulin Sales by Application (2027-2032) & (K Units) Table 156. Asia Icodec Insulin Sales Price by Application (2021-2026) & (US$/Unit) Table 157. Asia Icodec Insulin Sales Price by Application (2027-2032) & (US$/Unit) Table 158. Asia Icodec Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 159. Asia Icodec Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 160. Asia Icodec Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 161. Asia Icodec Insulin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 162. Asia Icodec Insulin Sales by Country (2021-2026) & (K Units) Table 163. Asia Icodec Insulin Sales by Country (2027-2032) & (K Units) Table 164. Asia Icodec Insulin Sales Price by Country (2021-2026) & (US$/Unit) Table 165. Asia Icodec Insulin Sales Price by Country (2027-2032) & (US$/Unit) Table 166. Japan Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 167. South Korea Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 168. India Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 169. Australia Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 170. Taiwan Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 171. Southeast Asia Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 172. SAMEA Icodec Insulin Revenue by Type (2021-2026) & (US$ Million) Table 173. SAMEA Icodec Insulin Revenue by Type (2027-2032) & (US$ Million) Table 174. SAMEA Icodec Insulin Sales by Type (2021-2026) & (K Units) Table 175. SAMEA Icodec Insulin Sales by Type (2027-2032) & (K Units) Table 176. SAMEA Icodec Insulin Sales Price by Type (2021-2026) & (US$/Unit) Table 177. SAMEA Icodec Insulin Sales Price by Type (2027-2032) & (US$/Unit) Table 178. SAMEA Icodec Insulin Revenue by Application (2021-2026) & (US$ Million) Table 179. SAMEA Icodec Insulin Revenue by Application (2027-2032) & (US$ Million) Table 180. SAMEA Icodec Insulin Sales by Application (2021-2026) & (K Units) Table 181. SAMEA Icodec Insulin Sales by Application (2027-2032) & (K Units) Table 182. SAMEA Icodec Insulin Sales Price by Application (2021-2026) & (US$/Unit) Table 183. SAMEA Icodec Insulin Sales Price by Application (2027-2032) & (US$/Unit) Table 184. SAMEA Icodec Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 185. SAMEA Icodec Insulin Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 186. SAMEA Icodec Insulin Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 187. SAMEA Icodec Insulin Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 188. SAMEA Icodec Insulin Sales by Country (2021-2026) & (K Units) Table 189. SAMEA Icodec Insulin Sales by Country (2027-2032) & (K Units) Table 190. SAMEA Icodec Insulin Sales Price by Country (2021-2026) & (US$/Unit) Table 191. SAMEA Icodec Insulin Sales Price by Country (2027-2032) & (US$/Unit) Table 192. Brazil Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 193. Argentina Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 194. Chile Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 195. Colombia Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 196. Peru Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 197. Saudi Arabia Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 198. Israel Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 199. UAE Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 200. Turkey Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 201. Iran Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 202. Egypt Icodec Insulin Revenue (2021-2032) & (US$ Million) Table 203. Key Raw Materials Table 204. Raw Materials Key Suppliers Table 205. Icodec Insulin Distributors List Table 206. Icodec Insulin Customers List Table 207. Research Programs/Design for This Report Table 208. Authors List of This Report Table 209. Secondary Sources Table 210. Primary Sources List of Figures Figure 1. Icodec Insulin Image Figure 2. Global Icodec Insulin Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Icodec Insulin Market Size Share 2021 VS 2025 VS 2032 Figure 4. Long-acting Image Figure 5. Medium-acting Image Figure 6. Global Icodec Insulin Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Icodec Insulin Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Icodec Insulin Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Icodec Insulin Revenue (2021-2032) & (US$ Million) Figure 12. Global Icodec Insulin Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Icodec Insulin Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Icodec Insulin Revenue Market Share by Region (2021-2032) Figure 15. Global Icodec Insulin Sales (2021-2032) & (K Units) Figure 16. Global Icodec Insulin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 17. Global Icodec Insulin Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Icodec Insulin Sales YoY (2021-2032) & (K Units) Figure 19. Europe Icodec Insulin Sales YoY (2021-2032) & (K Units) Figure 20. China Icodec Insulin Sales YoY (2021-2032) & (K Units) Figure 21. Asia (Excluding China) Icodec Insulin Sales YoY (2021-2032) & (K Units) Figure 22. South America, Middle East and Africa Icodec Insulin Sales YoY (2021-2032) & (K Units) Figure 23. Global Icodec Insulin Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Icodec Insulin Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Icodec Insulin Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Icodec Insulin Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Icodec Insulin Revenue Market Share by Type (2021-2032) Figure 29. Global Icodec Insulin Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Icodec Insulin Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Icodec Insulin Sales Market Share by Type (2021-2032) Figure 32. Global Icodec Insulin Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Icodec Insulin Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Icodec Insulin Revenue Market Share by Application (2021-2032) Figure 35. Global Icodec Insulin Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Icodec Insulin Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Icodec Insulin Sales Market Share by Application (2021-2032) Figure 38. North America Icodec Insulin Revenue Share by Type (2021-2032) Figure 39. North America Icodec Insulin Sales Share by Type (2021-2032) Figure 40. North America Icodec Insulin Revenue Share by Application (2021-2032) Figure 41. North America Icodec Insulin Sales Share by Application (2021-2032) Figure 42. North America Icodec Insulin Revenue Share by Country (2021-2032) Figure 43. North America Icodec Insulin Sales Share by Country (2021-2032) Figure 44. Europe Icodec Insulin Revenue Share by Type (2021-2032) Figure 45. Europe Icodec Insulin Sales Share by Type (2021-2032) Figure 46. Europe Icodec Insulin Revenue Share by Application (2021-2032) Figure 47. Europe Icodec Insulin Sales Share by Application (2021-2032) Figure 48. Europe Icodec Insulin Revenue Share by Country (2021-2032) Figure 49. Europe Icodec Insulin Sales Share by Country (2021-2032) Figure 50. China Icodec Insulin Revenue Share by Type (2021-2032) Figure 51. China Icodec Insulin Sales Share by Type (2021-2032) Figure 52. China Icodec Insulin Revenue Share by Application (2021-2032) Figure 53. China Icodec Insulin Sales Share by Application (2021-2032) Figure 54. Asia Icodec Insulin Revenue Share by Type (2021-2032) Figure 55. Asia Icodec Insulin Sales Share by Type (2021-2032) Figure 56. Asia Icodec Insulin Revenue Share by Application (2021-2032) Figure 57. Asia Icodec Insulin Sales Share by Application (2021-2032) Figure 58. Asia Icodec Insulin Revenue Share by Country (2021-2032) Figure 59. Asia Icodec Insulin Sales Share by Country (2021-2032) Figure 60. SAMEA Icodec Insulin Revenue Share by Type (2021-2032) Figure 61. SAMEA Icodec Insulin Sales Share by Type (2021-2032) Figure 62. SAMEA Icodec Insulin Revenue Share by Application (2021-2032) Figure 63. SAMEA Icodec Insulin Sales Share by Application (2021-2032) Figure 64. SAMEA Icodec Insulin Revenue Share by Country (2021-2032) Figure 65. SAMEA Icodec Insulin Sales Share by Country (2021-2032) Figure 66. Icodec Insulin Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Icodec Insulin Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Long-acting
  • Medium-acting
Applications
  • Hospital
  • Clinic
Companies covered
  • Paijin Biotechnology
  • Sanofi
  • Lilly
  • Gan&Lee Pharmaceuticals
  • Novo Nordisk

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Icodec Insulin Market by Type
  3. 1.2.1 Global Icodec Insulin Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Long-acting
  5. 1.2.3 Medium-acting
  6. 1.3 Icodec Insulin Market by Application
  7. 1.3.1 Global Icodec Insulin Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Icodec Insulin Market Dynamics
  1. 2.1 Icodec Insulin Industry Trends
  2. 2.2 Icodec Insulin Industry Drivers
  3. 2.3 Icodec Insulin Industry Opportunities and Challenges
  4. 2.4 Icodec Insulin Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Icodec Insulin Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Icodec Insulin Revenue by Region
  3. 3.2.1 Global Icodec Insulin Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Icodec Insulin Revenue by Region (2021-2026)
  5. 3.2.3 Global Icodec Insulin Revenue by Region (2027-2032)
  6. 3.2.4 Global Icodec Insulin Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Icodec Insulin Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Icodec Insulin Sales by Region
  9. 3.4.1 Global Icodec Insulin Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Icodec Insulin Sales by Region (2021-2026)
  11. 3.4.3 Global Icodec Insulin Sales by Region (2027-2032)
  12. 3.4.4 Global Icodec Insulin Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Icodec Insulin Revenue by Manufacturers
  2. 4.1.1 Global Icodec Insulin Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Icodec Insulin Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Icodec Insulin Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Icodec Insulin Sales by Manufacturers
  6. 4.2.1 Global Icodec Insulin Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Icodec Insulin Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Icodec Insulin Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Icodec Insulin Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Icodec Insulin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Icodec Insulin Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Icodec Insulin Manufacturers, Product Type & Application
  13. 4.7 Global Icodec Insulin Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Icodec Insulin Market CR5 and HHI
  16. 4.8.2 2025 Icodec Insulin Tier 1, Tier 2, and Tier 3
5 Icodec Insulin Market by Type
  1. 5.1 Global Icodec Insulin Revenue by Type
  2. 5.1.1 Global Icodec Insulin Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Icodec Insulin Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Icodec Insulin Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Icodec Insulin Sales by Type
  6. 5.2.1 Global Icodec Insulin Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Icodec Insulin Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Icodec Insulin Sales Market Share by Type (2021-2032)
  9. 5.3 Global Icodec Insulin Price by Type
6 Icodec Insulin Market by Application
  1. 6.1 Global Icodec Insulin Revenue by Application
  2. 6.1.1 Global Icodec Insulin Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Icodec Insulin Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Icodec Insulin Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Icodec Insulin Sales by Application
  6. 6.2.1 Global Icodec Insulin Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Icodec Insulin Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Icodec Insulin Sales Market Share by Application (2021-2032)
  9. 6.3 Global Icodec Insulin Price by Application
7 Company Profiles
  1. 7.1 Paijin Biotechnology
  2. 7.1.1 Paijin Biotechnology Company Information
  3. 7.1.2 Paijin Biotechnology Business Overview
  4. 7.1.3 Paijin Biotechnology Icodec Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Paijin Biotechnology Icodec Insulin Product Portfolio
  6. 7.1.5 Paijin Biotechnology Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Icodec Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Icodec Insulin Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Lilly
  14. 7.3.1 Lilly Company Information
  15. 7.3.2 Lilly Business Overview
  16. 7.3.3 Lilly Icodec Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lilly Icodec Insulin Product Portfolio
  18. 7.3.5 Lilly Recent Developments
  19. 7.4 Gan&Lee Pharmaceuticals
  20. 7.4.1 Gan&Lee Pharmaceuticals Company Information
  21. 7.4.2 Gan&Lee Pharmaceuticals Business Overview
  22. 7.4.3 Gan&Lee Pharmaceuticals Icodec Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Gan&Lee Pharmaceuticals Icodec Insulin Product Portfolio
  24. 7.4.5 Gan&Lee Pharmaceuticals Recent Developments
  25. 7.5 Novo Nordisk
  26. 7.5.1 Novo Nordisk Company Information
  27. 7.5.2 Novo Nordisk Business Overview
  28. 7.5.3 Novo Nordisk Icodec Insulin Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novo Nordisk Icodec Insulin Product Portfolio
  30. 7.5.5 Novo Nordisk Recent Developments
8 North America
  1. 8.1 North America Icodec Insulin Market Size by Type
  2. 8.1.1 North America Icodec Insulin Revenue by Type (2021-2032)
  3. 8.1.2 North America Icodec Insulin Sales by Type (2021-2032)
  4. 8.1.3 North America Icodec Insulin Price by Type (2021-2032)
  5. 8.2 North America Icodec Insulin Market Size by Application
  6. 8.2.1 North America Icodec Insulin Revenue by Application (2021-2032)
  7. 8.2.2 North America Icodec Insulin Sales by Application (2021-2032)
  8. 8.2.3 North America Icodec Insulin Price by Application (2021-2032)
  9. 8.3 North America Icodec Insulin Market Size by Country
  10. 8.3.1 North America Icodec Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Icodec Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Icodec Insulin Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Icodec Insulin Market Size by Type
  2. 9.1.1 Europe Icodec Insulin Revenue by Type (2021-2032)
  3. 9.1.2 Europe Icodec Insulin Sales by Type (2021-2032)
  4. 9.1.3 Europe Icodec Insulin Price by Type (2021-2032)
  5. 9.2 Europe Icodec Insulin Market Size by Application
  6. 9.2.1 Europe Icodec Insulin Revenue by Application (2021-2032)
  7. 9.2.2 Europe Icodec Insulin Sales by Application (2021-2032)
  8. 9.2.3 Europe Icodec Insulin Price by Application (2021-2032)
  9. 9.3 Europe Icodec Insulin Market Size by Country
  10. 9.3.1 Europe Icodec Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Icodec Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Icodec Insulin Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Icodec Insulin Market Size by Type
  2. 10.1.1 China Icodec Insulin Revenue by Type (2021-2032)
  3. 10.1.2 China Icodec Insulin Sales by Type (2021-2032)
  4. 10.1.3 China Icodec Insulin Price by Type (2021-2032)
  5. 10.2 China Icodec Insulin Market Size by Application
  6. 10.2.1 China Icodec Insulin Revenue by Application (2021-2032)
  7. 10.2.2 China Icodec Insulin Sales by Application (2021-2032)
  8. 10.2.3 China Icodec Insulin Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Icodec Insulin Market Size by Type
  2. 11.1.1 Asia Icodec Insulin Revenue by Type (2021-2032)
  3. 11.1.2 Asia Icodec Insulin Sales by Type (2021-2032)
  4. 11.1.3 Asia Icodec Insulin Price by Type (2021-2032)
  5. 11.2 Asia Icodec Insulin Market Size by Application
  6. 11.2.1 Asia Icodec Insulin Revenue by Application (2021-2032)
  7. 11.2.2 Asia Icodec Insulin Sales by Application (2021-2032)
  8. 11.2.3 Asia Icodec Insulin Price by Application (2021-2032)
  9. 11.3 Asia Icodec Insulin Market Size by Country
  10. 11.3.1 Asia Icodec Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Icodec Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Icodec Insulin Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Icodec Insulin Market Size by Type
  2. 12.1.1 SAMEA Icodec Insulin Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Icodec Insulin Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Icodec Insulin Price by Type (2021-2032)
  5. 12.2 SAMEA Icodec Insulin Market Size by Application
  6. 12.2.1 SAMEA Icodec Insulin Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Icodec Insulin Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Icodec Insulin Price by Application (2021-2032)
  9. 12.3 SAMEA Icodec Insulin Market Size by Country
  10. 12.3.1 SAMEA Icodec Insulin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Icodec Insulin Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Icodec Insulin Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Icodec Insulin Value Chain Analysis
  2. 13.1.1 Icodec Insulin Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Icodec Insulin Production Mode & Process
  6. 13.2 Icodec Insulin Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Icodec Insulin Distributors
  9. 13.2.3 Icodec Insulin Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst